Webinars
EpiVax takes great pride in providing industry leading and thought provoking content.
Here you may find information on upcoming webinars such as registration and speaker info as well as links to pre-recorded webinars that have passed.
Please reach out to info@epivax.com should you encounter issues with any link.
4th Tregitope Update – Open Meeting May 11 2011
Posted on February 13, 2011 by Annie De GrootTregitopes are small peptidic regulatory T-cell epitopes derived from human immunoglobulins that activate regulatory T cells (Tregs). Tregitope therapy has broad-reaching implications, offering new treatments for autoimmune diseases (e.g. type 1 juvenile diabetes, multiple sclerosis, rheumatoid arthritis, and lupus), allergies, and transplantation rejection. In previous meetings, the members of the Tregitope Collaborators team have demonstrated ...Read moreImmunogenicity Determinants and Correlates: Registration Now Open
Posted on February 13, 2011 by Annie De GrootImmunogenicity: Determinants and Correlates is a non-commercial meeting, sponsored by the Institute for Immunology and Informatics and organized by individuals from a wide range of backgrounds including industry and academic settings. The current agenda, confirmed speakers, and the registration website are now posted for your review.Read moreImmunogenicity Seminar @ Westin Tokyo 2011
Posted on February 5, 2011 by Annie De GrootExpert immunologist and Biotech CEO Dr. Annie De Groot of EpiVax, Inc. who is also faculty member of the Brown University Medical School and Professor at the University of Rhode Island, will provide a detailed discussion of immunogenicity and tolerance for a highly selected audience. We will address the following important questions: (1) What drives the ...Read moreImmunogenicity: Determinants and Correlates
Posted on January 25, 2011 by Annie De GrootSAVE THE DATE May 9, 10 and 11 1st Immunogenicity – Determinates and Correlates Providence, RIRead moreImmunogenicity, Tregitopes and Tolerance 2011
Posted on December 21, 2010 by Annie De GrootAnnie De Groot, EpiVax CEO will be speaking at the following conferences. Please click on the links for more information. We look forward to meeting you there! Invited Speaker. Regulating Immune Response in Biologics – A Paradigm- Shifting Solution. Session: Immunogenicity Issues. 2nd Annual Advancing Biologics from the Lab to the Clinic, Amsterdam, Netherlands. January 25-26, ...Read more